Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Astrazeneca Plc (AZN.LN)

Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 187,857,480
  • Shares Outstanding, K 1,550,235
  • Annual Sales, $ 45,811 M
  • Annual Income, $ 5,955 M
  • 60-Month Beta N/A
  • Price/Sales 4.99
  • Price/Cash Flow 24.51
  • Price/Book 6.30
Trade AZN.LN with:
  • Price/Earnings ttm 37.58
  • Earnings Per Share ttm 4.05
  • Most Recent Earnings $1.40 on 04/25/24
  • Latest Earnings Date N/A
  • Annual Dividend & Yield 2.89 (1.88%)
  • Most Recent Dividend 1.560 on 02/22/24
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
10,618.000 +16.14%
on 04/10/24
12,488.000 -1.25%
on 04/29/24
+1,623.999 (+15.17%)
since 04/09/24
3-Month
9,461.000 +30.35%
on 02/12/24
12,488.000 -1.25%
on 04/29/24
+2,570.999 (+26.34%)
since 02/09/24
52-Week
9,461.000 +30.35%
on 02/12/24
12,488.000 -1.25%
on 04/29/24
+418.000 (+3.51%)
since 05/09/23

Most Recent Stories

More News
AstraZeneca pulls its COVID-19 vaccine from the European market

The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled

$SPX : 5,206.64 (+0.37%)
$DOWI : 39,265.70 (+0.54%)
$IUXX : 18,119.13 (+0.19%)
AZN.LN : 12,332.000 (+0.55%)
AZN : 77.44 (+0.61%)
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition

The Federal Trade Commission is challenging patents on 20 brand-name drugs, including the blockbuster weight-loss injection Ozempic

AZN.LN : 12,332.000 (+0.55%)
AZN : 77.44 (+0.61%)
GSK.LN : 1,780.500 (+0.39%)
GSK : 44.54 (+0.91%)
International Paper, Unilever rise; Super Micro, Freeport-McMoRan fall, Tuesday, 3/19/2024

Stocks that traded heavily or had substantial price changes on Tuesday: International Paper, Unilever rise; Super Micro, Freeport-McMoRan fall

SMCI : 801.01 (-2.63%)
IP : 39.77 (+1.25%)
CRNX : 49.89 (-1.97%)
AZN.LN : 12,332.000 (+0.55%)
AZN : 77.44 (+0.61%)
FUSN : 21.39 (-0.05%)
FCX : 50.88 (+1.84%)
UL : 53.41 (+1.37%)
ULVR.LN : 4,266.000 (+0.87%)
Stocks Slip Before the Open as Investors Await Earnings Reports, Disney Climbs on Strong Results

March S&P 500 E-Mini futures (ESH24) are down -0.18%, and March Nasdaq 100 E-Mini futures (NQH24) are down -0.16% this morning as market participants braced for the next round of quarterly results.

ESH24 : 5,101.67s (-1.01%)
NQH24 : 17,854.75s (-0.94%)
DIS : 105.69 (+0.24%)
EMR : 114.76 (+1.87%)
CMG : 3,204.71 (+0.67%)
F : 12.14 (-0.08%)
VFC : 12.62 (+0.24%)
SNAP : 16.18 (-3.35%)
COP : 123.78 (+0.59%)
PM : 98.85 (+0.61%)
DUK : 102.66 (+0.27%)
EXPE : 112.29 (+0.67%)
Stock market today: Asian shares are mixed ahead of the Fed's decision on interest rates

Asian shares are mixed after Wall Street rose to its highest level since early 2022, slightly below its record high, after a report showed inflation in the United States is behaving pretty much as expected...

M : 19.37 (+1.63%)
GOOGL : 169.25 (-0.08%)
ADBE : 482.77 (-1.09%)
HAS : 61.16 (-0.26%)
AZN.LN : 12,332.000 (+0.55%)
AZN : 77.44 (+0.61%)
$SPX : 5,206.64 (+0.37%)
$DOWI : 39,265.70 (+0.54%)
$IUXX : 18,119.13 (+0.19%)
ORCL : 116.65 (-0.63%)
NVDA : 891.68 (-1.38%)
FB : 196.64 (+0.51%)
Oracle, Hasbro fall; Icosavax, Perion Network rise, Tuesday, 12/12/2023

Stocks that traded heavily or had substantial price changes on Tuesday: Oracle, Hasbro fall; Icosavax, Perion Network rise

CHH : 116.90 (+1.04%)
PFE : 28.11 (+0.93%)
AZN.LN : 12,332.000 (+0.55%)
AZN : 77.44 (+0.61%)
ORCL : 116.65 (-0.63%)
HAS : 61.16 (-0.26%)
3 stocks that crushed earnings estimates and still tanked

Every earnings season, regardless of sector or industry, has its share of stocks that go down even after beating earnings expectations such as these stocks

AZN : 77.44 (+0.61%)
SGHC : 3.50 (unch)
WIX : 122.88 (+1.46%)
INTU : 629.93 (-0.40%)
AZN.LN : 12,332.000 (+0.55%)
AZNCF : 147.6500 (-3.12%)
10 drugs targeted for Medicare price negotiations as Biden pitches cost reductions

President Joe Biden is touting his administration's efforts to lower medical costs

NVS : 99.91 (+0.31%)
MKKGY : 33.5150 (+1.38%)
PFE : 28.11 (+0.93%)
JNJ : 149.62 (+0.45%)
AMGN : 313.15 (+1.90%)
AZN.LN : 12,332.000 (+0.55%)
AZN : 77.44 (+0.61%)
BMY : 44.18 (+1.17%)
Babies should get recently approved drug for RSV, CDC says

U.S. health officials are recommending that babies get a recently approved drug to protect them against a respiratory virus

PFE : 28.11 (+0.93%)
GSK.LN : 1,780.500 (+0.39%)
GSK : 44.54 (+0.91%)
AZN.LN : 12,332.000 (+0.55%)
AZN : 77.44 (+0.61%)
7 Best Cancer Stocks to Invest in Now

The second-largest cause of death in the U.S., more than 600,000 deaths from cancer will occur in 2023. Learn about the best cancer stocks to invest in now.

EXEL : 21.67 (+0.37%)
GILD : 64.86 (-0.09%)
NVS : 99.91 (+0.31%)
ON : 71.60 (+1.32%)
PFE : 28.11 (+0.93%)
MDCO : 84.90 (-0.07%)
MRK : 130.14 (+0.46%)
KURA : 20.91 (+1.75%)
AZN.LN : 12,332.000 (+0.55%)
BGNE : 168.11 (+2.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 12,810.667
2nd Resistance Point 12,597.333
1st Resistance Point 12,430.667
Last Price 12,332.000
1st Support Level 12,050.667
2nd Support Level 11,837.333
3rd Support Level 11,670.667

See More

52-Week High 12,488.000
Last Price 12,332.000
Fibonacci 61.8% 11,331.686
Fibonacci 50% 10,974.500
Fibonacci 38.2% 10,617.313
52-Week Low 9,461.000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar